145 related articles for article (PubMed ID: 7869761)
41. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
42. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
43. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
44. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
[TBL] [Abstract][Full Text] [Related]
45. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
46. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
[TBL] [Abstract][Full Text] [Related]
47. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
Drach J; Drach D; Glassl H; Gattringer C; Huber H
Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
[TBL] [Abstract][Full Text] [Related]
49. Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitors.
Reuss-Borst MA; Jaschonek K; Müller CA
Leukemia; 1996 May; 10(5):923-4. PubMed ID: 8656693
[No Abstract] [Full Text] [Related]
50. Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature.
McIlwain L; Sokol L; Moscinski LC; Saba HI
Eur J Haematol; 2003 Apr; 70(4):242-5. PubMed ID: 12656749
[TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging follow-up in patients with acute leukemia during induction chemotherapy.
Kusnierz-Glaz C; Reiser M; Hagemeister B; Büchner T; Hiddemann W; van de Loo J
Haematol Blood Transfus; 1990; 33():351-6. PubMed ID: 2323641
[No Abstract] [Full Text] [Related]
52. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Garand R; Voisin S; Papin S; Praloran V; Lenormand B; Favre M; Philip P; Bernier M; Vanhaecke D; Falkenrodt A
Leukemia; 1993 Feb; 7(2):161-7. PubMed ID: 8426469
[TBL] [Abstract][Full Text] [Related]
53. [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
Doi T; Sakamaki S; Koike K; Matsunaga T; Kobayashi D; Muramatsu H; Sato T; Watanabe N; Kougo Y; Niitsu Y
Rinsho Ketsueki; 1996 Aug; 37(8):676-81. PubMed ID: 8827877
[TBL] [Abstract][Full Text] [Related]
54. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
55. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases.
Sempere A; Jarque I; Guinot M; Palau J; García R; Sanz GF; Gomis F; Pérez-Sirvent ML; Senent L; Sanz MA
Leuk Lymphoma; 1993 Dec; 12(1-2):103-8. PubMed ID: 8161925
[TBL] [Abstract][Full Text] [Related]
56. Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes.
Sucić M; Boban D; Marković-Glamocak M; Uzarević B; Zadro R; Petrovecki M; Ries S; Gjadrov K; Golemović M; Stavljenić-Rukavina A; Labar B; Batinić D
J Hematother Stem Cell Res; 1999 Dec; 8(6):635-43. PubMed ID: 10645771
[TBL] [Abstract][Full Text] [Related]
57. Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features.
Bassan R; Biondi A; Benvestito S; Tini ML; Abbate M; Viero P; Barbui T; Rambaldi A
Cancer; 1992 Jan; 69(2):396-404. PubMed ID: 1370211
[TBL] [Abstract][Full Text] [Related]
58. Clonality switch in acute myeloid leukemia.
Yin JA; Jowitt SN
Leuk Lymphoma; 1996 Jun; 22(1-2):125-30. PubMed ID: 8724539
[TBL] [Abstract][Full Text] [Related]
59. Acute trilineage leukemia with monosomy of chromosome 7 following an acute promyelocytic leukemia.
Felice MS; Rossi J; Gallego M; Zubizarreta PA; Cygler AM; Alfaro E; Sackmann-Muriel F
Leuk Lymphoma; 1999 Jul; 34(3-4):409-13. PubMed ID: 10439380
[TBL] [Abstract][Full Text] [Related]
60. Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases.
Cuneo A; Ferrant A; Michaux JL; Bosly A; Chatelain B; Stul M; Dal Cin P; Dierlamm J; Cassiman JJ; Hossfeld DK; Castoldi G; Van den Berghe H
Cancer Genet Cytogenet; 1996 Nov; 92(1):31-6. PubMed ID: 8956868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
